As about 70% of all human cases of aniridia result from premature termination codon (PTC) mutations leading to nonsense-mediated PAX6 protein decay (6, 7), this mutation type is the most useful for investigating disease mechanisms. The gene discussed is PAX6; the disease is aniridia.